CALNEX SOLUT. LS -,00125 Action · GB00BMBK7016 · A2QEGT (XLON) — cotations en temps réel, données d'entreprise, dividendes, fondamentaux et analyse de portefeuille IA sur MoneyPeak

Calnex Solutions plc designs, produces, and markets test instrumentation and solutions for network synchronization, and network emulation for telecoms networks, enterprise networks, and data centers worldwide. The company offers Paragon-neo, a platform that provides PTP and SyncE testing to 400GbE and sub-nanosecond accuracy for 5G networks; NE-ONE, a performance test application for realistic networks, including LAN, WAN, Internet, Cloud, Wi-Fi, (A)DSL, mobile, and satellite to verify application performance; Calnex SNE, a solution for network emulation and simulation, which enables users to build their network; Sentinel, a field solution for 3G/4G/5G mobile backhaul, E911/critical infrastructure, financial networks, and power comms; Paragon-ONE, a feature that bundles delivering test solutions for PTP to profiles, such as IEEE 802.1AS/AS-REV, SMPTE 2059-2, and ITU-T G.8275.1.; and Paragon-X, a solution to test SyncE, PTP, and NTP mechanisms, as well as E1/T1 sync interfaces and ethernet OAM. It also provides Attero-100G for 100/40/25GbE device performance testing; Attero-X, a network emulation test solution; Attero-V, a virtual impairments tool that extends and complements the capabilities of the Spirent range of virtualization products and solutions; and Tempo for canned tests for embedded GPS/GLONASS/BEDOU receiver and optional mini rubidium. In addition, the company offers Rb/GPS, a frequency reference, which provides a stable 10MHz and a 1pps measurement reference for Sync testers; 1pps/ToD/Frequency Converter that enables the users to convert essential signals required in modern network devices; and Calnex Analysis Tool, a network and device analysis software. It offers its products through a network of regional resellers and distributors. The company was incorporated in 2006 and is headquartered in Linlithgow, the United Kingdom.